Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Users Online: 620 | Home Print this page Email this page Small font size Default font size Increase font size
Year : 2012  |  Volume : 32  |  Issue : 5  |  Page : 12

OA01.12. A clinical study of efficacy of Vyoshadi gutika and Pippalayadi churna avapida nasya in the management of Pratishyaya

Pt. Ravishankar shukla university, Raipur (Chattisgarh), India

Correspondence Address:
Vivek Sharma
Pt. Ravishankar shukla university, Raipur (Chattisgarh)
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Purpose: Pratishyay basically is a Vat-kaphaj disorder arising from accumulation of vitiated Vat along with kaph-pitta-rakta in uttamang (shirh pradesh) and comparable to Rhinitis which describes a group of symptoms including runny nose, stuffiness, sneezing usually due to common cold, environmental irritants and immunodeficiency. This study aim to do 1.Evaluation of effectiveness of Vyoshadi gutika (samshaman therapy) and Pippalayadi churna Avapida nasya (samshodhan therapy) in the management of pratishyay, 2.Statistical assessment of data post treatment. Method: 60 patients of Pratishyay aged between 16-60 years of age of both sexes complaining of Rhinorrhoea/ nasal block, sneezing, heaviness of head, anosmia were selected randomly and assigned for clinical study were divided into 2 groups. Group A consisting of 30 patients had internal administration of Vyoshadi gutika in a dose of 2 tablets QID (each tab. 375 mg) with lukewarm water for 30 days. Group B- 30 patients took Vyoshadi gutika along with Pippalayadi churna Avapida nasya (6 drops in each nostril early morning) for duration of 21 days. All patients were advised to attend 15 days Intercal regularly for 3 months for assessment of disease through subjective and objective parameters. Result: 60% patients (18 no.) of Group B while 47% patients (14 no.) Group A responded satisfactorily with maximum improvement (more than 76% symptomatic improvement). Similarly, Moderate improvement (between 51-75%) was seen in 47 patients of Group A and 37% of Group B while mild improvement in 10% and 3% patients of Group A and B respectively. No untoward adverse effects were seen in any patients. Conclusion: It can be concluded that on the basis of Practical, Therapeutic and Statistical analysis, patients of both groups got satisfactory improvement. Besides, patients treated with both Samshodhan Nasya therapy and Samshaman Vyoshadi Gutika therapy comparatively got better results.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded86    
    Comments [Add]    

Recommend this journal